Jack Lin

Jack Lin

Company: Harpoon Therapeutics

Job title: Director of New Technologies


ProTriTAC: A New Protease-Activated T Cell Engager Platform to Target Broadly Expressed Tumor Antigens 11:00 am

ProTriTAC is a T cell engager prodrug with tumor-restricted activity for improved safety Half-life extension is coupled to functional masking for added protection Expansion of therapeutic index was demonstrated with rodent and non-human primate modelsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.